Written question asked by Lord Warner (Crossbench) on Tuesday, 8 January 2019, in the House of Lords. It was due for an answer on Tuesday, 22 January 2019. It was answered by Baroness Manzoor (Conservative) on Tuesday, 22 January 2019 on behalf of the Department of Health and Social Care.
NHS: Drugs
- Question
-
To ask Her Majesty's Government why the proposed changes to the Human Medicines Regulation 2012, as outlined in the document Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal, published on 4 January, will not be subject to the affirmative instrument procedure.
- Answer
-
The proposed changes to the Human Medicines Regulation 2012 will be subject to the affirmative resolution procedure in accordance with paragraph 1(1) of Schedule 7 to the European Union (Withdrawal) Act 2018 for it to be exercisable in the United Kingdom. The Statutory Instrument will be laid before Parliament very soon.
Secondary information
- Type
- Written question
- Reference
- HL12687
- Session
- 2017-19
- Subjects
- Drugs NHS Parliamentary scrutiny Brexit
- Legislation
- Human Medicines Regulations 2012
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2019-08-02 09:00:49 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2017-19/HL12687
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2017-19/HL12687
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2017-19/HL12687